- Home
- GDHG vs MYNZ Comparison
GDHG vs MYNZ Comparison
Compare GDHG & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- MYNZ
- Stock Information
- Founded
- GDHG 2008
- MYNZ 2021
- Country
- GDHG China
- MYNZ Germany
- Employees
- GDHG N/A
- MYNZ N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- GDHG Consumer Discretionary
- MYNZ Health Care
- Exchange
- GDHG Nasdaq
- MYNZ Nasdaq
- Market Cap
- GDHG 9.0M
- MYNZ 7.2M
- IPO Year
- GDHG 2023
- MYNZ 2021
- Fundamental
- Price
- GDHG $0.30
- MYNZ $3.22
- Analyst Decision
- GDHG
- MYNZ Buy
- Analyst Count
- GDHG 0
- MYNZ 2
- Target Price
- GDHG N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- GDHG 5.0M
- MYNZ 115.9K
- Earning Date
- GDHG 04-25-2025
- MYNZ 04-29-2025
- Dividend Yield
- GDHG N/A
- MYNZ N/A
- EPS Growth
- GDHG N/A
- MYNZ N/A
- EPS
- GDHG N/A
- MYNZ N/A
- Revenue
- GDHG $22,333,251.00
- MYNZ $893,991.00
- Revenue This Year
- GDHG N/A
- MYNZ $42.95
- Revenue Next Year
- GDHG N/A
- MYNZ N/A
- P/E Ratio
- GDHG N/A
- MYNZ N/A
- Revenue Growth
- GDHG N/A
- MYNZ N/A
- 52 Week Low
- GDHG $0.25
- MYNZ $0.18
- 52 Week High
- GDHG $19.00
- MYNZ $8.20
- Technical
- Relative Strength Index (RSI)
- GDHG 37.31
- MYNZ 39.69
- Support Level
- GDHG $0.25
- MYNZ $3.09
- Resistance Level
- GDHG $0.46
- MYNZ $3.54
- Average True Range (ATR)
- GDHG 0.46
- MYNZ 0.47
- MACD
- GDHG -0.13
- MYNZ 0.06
- Stochastic Oscillator
- GDHG 0.82
- MYNZ 57.58
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.